LINC01103

Across TCGA pan-cancer cohorts, LINC01103 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01103 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC01103 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01103 expression acts as an unfavorable survival marker, although some lineages such as LGG and UVM show a favorable association.

CESC, KICH, and BLCA are the cancer types where LINC01103 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	II,III,IV	0.124	0.711	<.001	90	view →
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	63	view →
BLCA	OS	Tertile	IV	0.198	0.619	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.086	0.664	<.001	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
ACC	OS	Tertile	All	0.214	0.820	.006	33	view →
THCA	OS	Tertile	III,IV	0.857	0.982	<.001	30	view →
LGG	DFS	Median	All	0.535	0.300	<.001	25	view →
KIRC	DFS	Tertile	II,III,IV	0.603	0.718	.016	21	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →
UVM	DFS	Tertile	All	0.794	0.466	.024	12	view →
KIRP	OS	Median	All	1.000	0.834	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01103–CESC (DFS)

Open the CESC breakdown →